§ 520.623 Diethylcarbamazine and oxibendazole chewable tablets.
Primary source
Verbatim text below is from the Electronic Code of Federal Regulations (eCFR), a public-domain U.S. government work. Always verify the current version with the eCFR before relying on it for any legal matter.
Full Text
Specifications.(a) Each tablet contains either 60, 120, or 180 milligrams of diethylcarbamazine citrate with 45, 91, or 136 milligrams of oxibendazole, respectively.
Sponsor.(b) See No. 054771 in § 510.600(c) of this chapter.
Conditions of use in dogsAmount.(c) —(1) Administer orally to dogs at a dosage level of 6.6 milligrams of diethylcarbamazine citrate per kilogram of body weight (3 milligrams per pound of body weight) and 5.0 milligrams of oxibendazole per kilogram of body weight (2.27 milligrams per pound of body weight).
Indications for use.Dirofilaria immitisAncylostoma caninumTrichuris vulpisToxocara canis(2) For prevention of infection with (heartworm disease) and (hookworm infection) and for removal and control of (whipworm infection) and mature and immature stages of intestinal (ascarid infection).
Limitations.(3) Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[50 FR 28768, July 16, 1985, as amended at 53 FR 45759, Nov. 14, 1988; 54 FR 3776, Jan. 26, 1989; 54 FR 6804, Feb. 14, 1989; 56 FR 50653, Oct. 8, 1991; 60 FR 55659, Nov. 2, 1995; 79 FR 28820, May 20, 2014]
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.